1. The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors. Issue 9 (27th July 2021) Authors: Blanchard, Valentin; Chemello, Kévin; Hollstein, Tim; Hong-Fong, Clément Chong; Schumann, Friederike; Grenkowitz, Thomas; Nativel, Brice; Coassin, Stefan; Croyal, Mikaël; Kassner, Ursula; Lamina, Claudia; Steinhagen-Thiessen, Elisabeth; Lambert, Gilles Journal: Cardiovascular research Issue: Volume 118:Issue 9(2022) Page Start: 2103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗